Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

Evolus back in the Botox biosimilar race, says GlobalData

Following the announcement that the FDA have accepted Evolus’ BLA resubmission for their Botox biosimilar, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what this could mean for pharma company: “Evolus had their previous BLA submission rejected by the FDA in May 2018 due to concerns over […]
Read more

Merck & Co can expect strong sales of Doravirine-based Drugs after Double-Approval, but not Blockbuster Status, says GlobalData

Following the announcement that Merck & Co has been granted FDA approval for two HIV drugs, Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate) and Pifeltro (doravirine), Thomas Moore, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: ‘‘This approval comes at a good time for Merck & Co, which […]
Read more

UK medical devices industry faces uncertain future as it struggles to accommodate regulatory change in the headwinds of Brexit, says GlobalData

For medical devices, Brexit is coming at an inopportune time says GlobalData, a leading data and analytics company. EU Directives are currently transitioning to a new Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), which is already having a profound impact on the medical devices industry and on the availability of medical devices […]
Read more

Coca-Cola acquisition of Costa Coffee provides a route into projected US$34.2bn retail hot drinks market in China, says GlobalData

As Whitbread announces (Friday 31st August) it is to sell its Costa Coffee chain to Coca-Cola in a £3.9bn deal, Jonathan Davison, Beverage Analyst at GlobalData, a leading data and analytics company, offers his verdict on the breaking news: “This move will have appealed to Coca-Cola for two reasons. The most apparent is the potential […]
Read more

Consumer trend towards beauty brands with a commitment to mitigating their environmental impact to be explored by GlobalData’s Lia Neophytou at Packaging Innovations 2018

The Beauty Forum at Packaging Innovations 2018, which takes place in London (September 12th), will unveil the latest innovations and trends occurring in the dynamic packaging industry. The shift toward sustainability will be a key topic of focus at the event, while the potential for plastic-free packaging will also be explored. Lia Neophytou, Associate Consumer […]
Read more

Washington State developing drugs to combat nicotine addiction is a step in the right direction

Following the announcement that Washington State University are developing drugs to treat nicotine addiction, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what this could mean for the addiction market and if this research could be used in other addiction indications: “Scientists at Washington State University recently […]
Read more

PepsiCo’s purchase of SodaStream a sign of big beverage industry’s plastic waste worries, says GlobalData

Anyone looking for proof that the beverage industry is worried about the “war on plastic” got it on August 20th when PepsiCo announced an agreement to purchase Israel-based SodaStream International for the hefty price of $3.2 billion, says GlobalData, a leading data and analytics company. That price represents almost a one-third premium over the carbonated […]
Read more

BIOplus 2018 : Game-changing insights and the latest research on immune checkpoint inhibitors for cancer therapy from GlobalData’s Fern Barkalow

BIOplus 2018 which takes place in Seoul next month (September 6th – 7th), will reveal the latest global intelligence in biotech and healthcare developments, focusing on game-changing insights to help bio companies grow their business. Fern Barkalow, PhD, Healthcare Director of Oncology and Hematology at GlobalData will join a presentation panel on the subject of […]
Read more

Government technical papers indicate UK will be forced to relinquish control of pharma regulations to Europe in case of a ‘No-deal’ Brexit

Following the publication by the UK government (Thursday 23 August 2018) of 24 technical papers covering the likely impact of a no-deal Brexit, including five papers covering the healthcare sector, the pharmaceuticals industry now has some guidance on how to prepare for this eventuality and to some extent greater certainty over what to expect after Britain leaves the EU.
Read more

Eylea sales will tumble as brolucizumab gains traction

Following Regeneron’s announcement that the FDA issued a complete response letter (CRL) regarding its supplemental Biologics License Application (sBLA) of the 12-week injection dosing for Eylea (aflibercept) in patients with wet age-related macular degeneration (wet AMD), the labeling issue will likely heat already anticipated competition with rival Novartis’ new wet AMD drug, brolucizumab. Edit Kovalcsik, […]
Read more

Alternative payments outnumber traditional payment methods in APAC e-commerce market, finds GlobalData

Alternative payment methods such as mobile and digital wallets are steadily displacing traditional payment methods such as cards, bank transfers and cash/cheques in the Asia-Pacific (APAC) e-commerce market, finds leading data and analytics company GlobalData. The company forecasts the APAC e-commerce market to grow from $1.6 trillion in 2018 to $2.3 trillion in 2022. According […]
Read more

Indian players have to explore M&As and alliances to grab major slice of global biosimilar pie, says GlobalData

Biopharmaceuticals accounted for nearly 25% of the global pharmaceutical market revenues from marketed drugs (~$1,100bn) in 2016. To add to this, the patent expiry of the leading 10 biologic drugs represents a massive $70bn opportunity for pharma companies over the period 2015-2020. Against this backdrop, Indian generic pharma players will have to explore M&As and […]
Read more
1 … 45 46 47 48 49 … 61